Ocumension Therapeutics (Suzhou) Co., Ltd

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children

Phase 3
Completed
Conditions
Interventions
First Posted Date
2024-11-20
Last Posted Date
2024-11-20
Lead Sponsor
Ocumension Therapeutics (Suzhou) Co., Ltd
Target Recruit Count
148
Registration Number
NCT06697522
Locations
🇨🇳

Beijing Children's Hospital, Capital Medical University, Beijing, China

© Copyright 2024. All Rights Reserved by MedPath